Mechanisms related to the pathophysiology and management of central hypothyroidism

Nature Clinical Practice Endocrinology and Metabolism

Volumn 4, Issue 12, 2008, Pages 683-694

  Yamada, Masanobu ^a   Mori, Masatomo ^a  

^a GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Bexarotene; GH therapy; Subarachnoid hemorrhage; Traumatic brain injury; TSH releasing hormone

Indexed keywords

ALPHA INTERFERON; BEXAROTENE; CARBAMAZEPINE; GLUCOCORTICOID; GROWTH HORMONE; LEVOTHYROXINE; LIOTHYRONINE; PROTIRELIN; THYROTROPIN; THYROXINE;

CENTRAL HYPOTHYROIDISM; COLD SENSITIVITY; COMBINATION CHEMOTHERAPY; CRANIOPHARYNGIOMA; DISEASE MODEL; DISEASE PREDISPOSITION; DRUG MEGADOSE; EMPTY SELLA SYNDROME; FATIGUE; GENE MUTATION; GENETIC ASSOCIATION; GRAVES DISEASE; HESX1 GENE; HORMONAL THERAPY; HORMONE ACTION; HORMONE DEFICIENCY; HUMAN; HUMAN GENOME; HYDROCORTISONE BLOOD LEVEL; HYPERTRIGLYCERIDEMIA; HYPOPHYSIS; HYPOPHYSIS ADENOMA; HYPOPHYSIS APOPLEXY; HYPOPHYSIS THYROID SYSTEM; HYPOPHYSIS TUMOR; HYPOPHYSITIS; HYPOPITUITARISM; HYPOTHALAMUS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS TUMOR; HYPOTHYROIDISM; LHX3 GENE; LHX4 GENE; LIOTHYRONINE BLOOD LEVEL; MONOTHERAPY; NONHUMAN; OPTIMAL DRUG DOSE; PATHOPHYSIOLOGY; POU1F1 GENE; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROP1 GENE; RADIATION; RECOMMENDED DRUG DOSE; REVIEW; SIDE EFFECT; SOX3 GENE; SUBARACHNOID HEMORRHAGE; T CELL LYMPHOMA; THYROID GLAND; THYROTROPIN BLOOD LEVEL; THYROTROPIN RELEASE; THYROXINE BLOOD LEVEL; TRAUMATIC BRAIN INJURY; TRHR GENE; TRIACYLGLYCEROL BLOOD LEVEL; TSHB GENE;

HORMONE REPLACEMENT THERAPY; HUMANS; HYPOTHYROIDISM; INFANT, NEWBORN; MODELS, BIOLOGICAL; THYROTROPIN; THYROXINE;

EID: 56649111212     PISSN: 17458366     EISSN: 17458374     Source Type: Journal    
DOI: 10.1038/ncpendmet0995     Document Type: Review

References (71)

1. Schneider HJ et al. (2007) Hypopituitarism. Lancet 369: 1461-1470
2. Martino E et al. (2005) Central hypothyroidism. In Werner and Ingabar's The Thyroid: A Fundamental and Clinical Text, 754-768, edn 9 (Eds Braverman LE and Utiger RD) Philadelphia, PA: Lippincott Williams & Wilkins
3. van Tijn DA et al. (2005) Neonatal detection of congenital hypothyroidism of central origin. J Clin Endocrinol Metab 90: 3350-3359
4. Regal M et al. (2001) Prevalence and incidence of hypopituitarism in an adult Caucasian population in northwestern Spain. Clin Endocrinol (Oxf) 55: 735-740
5. Arafah BM (2002) Medical management of hypopituitarism in patients with pituitary adenomas. Pituitary 5: 109-117
6. Arafah BM et al. (2000) The dominant role of increased intrasellar pressure in the pathogenesis of hypopituitarism, hyperprolactinemia, and headaches in patients with pituitary adenomas. J Clin Endocrinol Metab 85: 1789-1793
7. Arafah BM (1986) Reversible hypopituitarism in patients with large nonfunctioning pituitary adenomas. J Clin Endocrinol Metab 62: 1173-1179
8. Tominaga A et al. (1995) Anterior pituitary function in patients with nonfunctioning pituitary adenoma: results of longitudinal follow-up. Endocr J 42: 421-427
9. Faglia G et al. (1973) Plasma thyrotropin response to thyrotropin-releasing hormone in patients with pituitary and hypothalamic disorders. J Clin Endocrinol Metab 37: 595-601
10. Eskildsen PC et al. (1988) The pituitary-thyroid axis in acromegaly. Horm Metab Res 20: 755-757
11. Sibal L et al. (2002) Medical therapy of macroprolactinomas in males: I. Prevalence of hypopituitarism at diagnosis. II. Proportion of cases exhibiting recovery of pituitary function. Pituitary 5: 243-246
12. Lubina A et al. (2005) Management of pituitary apoplexy: clinical experience with 40 patients. Acta Neurochir (Wien) 147: 151-157
13. Zayour D et al. (2004) Extreme elevation of intrasellar pressure in patients with pituitary tumor apoplexy: relation to pituitary function. J Clin Endocrinol Metab 89: 5649-5654
14. Kendall-Taylor P et al. (2005) The clinical, metabolic and endocrine features and the quality of life in adults with childhood-onset craniopharyngioma compared with adult-onset craniopharyngioma. Eur J Endocrinol 152: 557-567
15. Honegger J et al. (1999) Surgical treatment of craniopharyngiomas: endocrinological results. J Neurosurg 90: 251-257
16. Nishioka H et al. (2006) Magnetic resonance imaging, clinical manifestations, and management of Rathke's cleft cyst. Clin Endocrinol (Oxf) 64: 184-188
17. Aho CJ et al. (2005) Surgical outcomes in 118 patients with Rathke cleft cysts. J Neurosurg 102: 189-193
18. Cohan P et al. (2004) Symptomatic Rathke's cleft cysts: a report of 24 cases. J Endocrinol Invest 27: 943-948
19. De Marinis L et al. (2005) Primary empty sella. J Clin Endocrinol Metab 90: 5471-5477
20. Cannavò S et al. (2002) Abnormalities of hypothalamic-pituitary-thyroid axis in patients with primary empty sella. J Endocrinol Invest 25: 236-239
21. Kelestimur F et al. (2005) Sheehan's syndrome: baseline characteristics and effect of 2 years of growth hormone replacement therapy in 91 patients in KIMS - Pfizer International Metabolic Database. Eur J Endocrinol 152: 581-587
22. Onose H et al. (2003) A case of Sheehan's syndrome with panhypopituitarism due to the impairment of both the hypothalamus and the pituitary. Endocrine J 50: 415-419
23. Oliveira JH et al. (2001) Investigating the paradox of hypothyroidism and increased serum thyrotropin (TSH) levels in Sheehan's syndrome: characterization of TSH carbohydrate content and bioactivity. J Clin Endocrinol Metab 86: 1694-1699
24. Bhandare N et al. (2007) Primary and central hypothyroidism after radiotherapy for head-and-neck tumors. Int J Radiat Oncol Biol Phys 68: 1131-1139
25. Kong DS et al. (2007) The efficacy of fractionated radiotherapy and stereotactic radiosurgery for pituitary adenomas: long-term results of 125 consecutive patients treated in a single institution. Cancer 110: 854-860
26. Schneider HJ et al. (2007) Hypothalamopituitary dysfunction following traumatic brain injury and aneurysmal subarachnoid hemorrhage: a systematic review. JAMA 298: 1429-1438
27. Benvenga S et al. (2000) Clinical review 113: hypopituitarism secondary to head trauma. J Clin Endocrinol Metab 85: 1353-1361
28. Aimaretti G and Ghigo E (2007) Should every patient with traumatic brain injury be referred to an endocrinologist? Nat Clin Pract Endocrinol Metab 3: 318-319
29. Sharma V et al. (2006) Effects of rexinoids on thyrotrope function and the hypothalamic-pituitary-thyroid axis. Endocrinology 147: 1438-1451
30. Duvic M et al. (2001) Phase 2 and 3 clinical trial of oral bexarotene (Targretin capsules) for the treatment of refractory or persistent early-stage cutaneous T-cell lymphoma. Arch Dermatol 137: 581-593
31. Golden WM et al. (2007) Single-dose rexinoid rapidly and specifically suppresses serum thyrotropin in normal subjects. J Clin Endocrinol Metab 92: 124-130
32. Sherman SI et al. (1999) Central hypothyroidism associated with retinoid X receptor-selective ligands. N Engl J Med 340: 1075-1079
33. Smit JW et al. (2007) Bexarotene-induced hypothyroidism: bexarotene stimulates the peripheral metabolism of thyroid hormones. J Clin Endocrinol Metab 92: 2496-2499
34. Macchia PE et al. (2002) RXR receptor agonist suppression of thyroid function: central effects in the absence of thyroid hormone receptor. Am J Physiol Endocrinol Metab 283: E326-E331
35. 4 therapy become mandatory? J Clin Endocrinol Metab 87: 2042-2045
36. Agha A et al. (2007) Unmasking of central hypothyroidism following growth hormone replacement in adult hypopituitary patients. Clin Endocrinol (Oxf) 66: 72-77
37. Wyatt DT et al. (1998) Changes in thyroid hormone levels during growth hormone therapy in initially euthyroid patients: lack of need for thyroxine supplementation. J Clin Endocrinol Metab 83: 3493-3497
38. Martins MR et al. (2007) Growth hormone replacement improves thyroxine biological effects: implications for management of central hypothyroidism. J Clin Endocrinol Metab 92: 4144-4153
39. Caturegli P et al. (2005) Autoimmune hypophysitis. Endocr Rev 26: 599-614
40. Hashimoto K et al. (2006) Longitudinal study of patients with idiopathic isolated TSH deficiency: possible progression of pituitary dysfunction in lymphocytic adenohypophysitis. Endocr J 53: 593-601
41. Skuza KA et al. (1996) Prediction of neonatal hyperthyroidism in infants born to mothers with Graves disease. J Pediatr 128: 264-268
42. Kempers M J et al. (2007) Neonatal screening for congenital hypothyroidism in the Netherlands: cognitive and motor outcome at 10 years of age. J Clin Endocrinol Metab 92: 919-924
43. Higuchi R et al. (2005) Central hypothyroidism in infants who were born to mothers with thyrotoxicosis before 32 weeks' gestation: 3 cases. Pediatrics 115: e623-e625
44. Matsuura N et al. (1997) The mechanisms of transient hypothyroxinemia in infants born to mothers with Graves' disease. Pediatr Res 42: 214-218
45. Kempers MJ et al. (2007) Loss of integrity of thyroid morphology and function in children born to mothers with inadequately treated Graves' disease. J Clin Endocrinol Metab 92: 2984-2991
46. Miyai K (2007) Congenital thyrotropin deficiency - from discovery to molecular biology, postgenome and preventive medicine. Endocr J 54: 191-203
47. Partsch CJ et al. (2006) Initially elevated TSH and congenital central hypothyroidism due to a homozygous mutation of the TSH beta subunit gene: case report and review of the literature. Exp Clin Endocrinol Diabetes 114: 227-234
48. Collu R et al. (1997) A novel mechanism for isolated central hypothyroidism: inactivating mutations in the thyrotropin-releasing hormone receptor gene. J Clin Endocrinol Metab 82: 1561-1565
49. Brown MR et al. (1998) Central hypothyroidism reveals compound heterozygous mutations in the Pit-1 gene. Horm Res 49: 98-102
50. Turton JP et al. (2005) Novel mutations within POU1F1 gene associated with variable combined pituitary hormone deficiency. J Clin Endocrinol Metab 90: 4762-4770
51. Mody S et al. (2002) The spectrum of hypopituitarism caused by PROP1 mutations. Best Pract Res Clin Endocrinol Metab 16: 421-431
52. Kelberman D et al. (2007) Hypopituitarism oddities: congenital causes. Hormone Res 68: 138-144
53. Yamada M et al. (1997) Tertiary hypothyroidism and hyperglycemia in mice with targeted disruption of the thyrotropin-releasing hormone gene. Proc Natl Acad Sci USA 94: 10862-10867
54. Rabeler R et al. (2004) Generation of thyrotropin-releasing hormone receptor 1-deficient mice as an animal model of central hypothyroidism. Mol Endocrinol 18: 1450-1460
55. Zeng H et al. (2007) Thyrotropin-releasing hormone receptor 1-deficient mice display increased depression and anxiety-like behavior. Mol Endocrinol 21: 2795-2804
56. Hernandez A et al. (2006) Type 3 deiodinase is critical for the maturation and function of the thyroid axis. J Clin Invest 116: 476-484
57. Hernandez A et al. (2007) Type 3 deiodinase deficiency results in functional abnormalities at multiple levels of the thyroid axis. Endocrinology 148: 5680-5687
58. Persani L et al. (2000) Circulating thyrotropin bioactivity in sporadic central hypothyroidism. J Clin Endocrinol Metab 85: 3631-3635
59. Beck-Peccoz P et al. (1985) Decreased receptor binding of biologically inactive thyrotropin in central hypothyroidism: effect of treatment with thyrotropin-releasing hormone. N Engl J Med 312: 1085-1090
60. Atmaca H et al. (2007) Do we still need the TRH stimulation test? Thyroid 17: 529-533
61. van Tijn DA et al. (2008) Role of the thyrotropin-releasing hormone stimulation test in diagnosis of congenital central hypothyroidism in infants. J Clin Endocrinol Metab 93: 410-419
62. Mehta A et al. (2003) Is the thyrotropin-releasing hormone test necessary in the diagnosis of central hypothyroidism in children. J Clin Endocrinol Metab 88: 5696-5703
63. Horimoto M et al. (1995) Bioactivity of thyrotropin (TSH) in patients with central hypothyroidism: comparison between in vivo 3,5,3′-triiodothyronine response to TSH and in vitro bioactivity of TSH. J Clin Endocrinol Metab 80: 1124-1128
64. Mönig H et al. (1999) Blunted nocturnal TSH surge does not indicate central hypothyroidism in patients after pituitary surgery. Exp Clin Endocrinol Diabetes 107: 89-92
65. Darzy KH and Shalet SM (2005) Circadian and stimulated thyrotropin secretion in cranially irradiated adult cancer survivors. J Clin Endocrinol Metab 90: 6490-6497
66. 4 and triiodothyronine. J Clin Endocrinol Metab 92: 4115-4122
67. Alexopoulou O et al. (2004) Clinical and hormonal characteristics of central hypothyroidism at diagnosis and during follow-up in adult patients. Eur J Endocrinol 150: 1-8
68. Arafah BM (2001) Increased need for thyroxine in women with hypothyroidism during estrogen therapy. N Engl J Med 344: 1743-1749
69. Grozinsky-Glasberg S et al. (2006) Thyroxine-triiodothyronine combination therapy versus thyroxine monotherapy for clinical hypothyroidism: meta-analysis of randomized controlled trials. J Clin Endocrinol Metab 91: 2592-2599
70. Ferretti E et al. (1999) Evaluation of the adequacy of levothyroxine replacement therapy in patients with central hypothyroidism. J Clin Endocrinol Metab 84: 924-929
71. Webb SM et al. (1999) Recovery of hypopituitarism after neurosurgical treatment of pituitary adenomas. J Clin Endocrinol Metab 84: 3696-3700